“Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading”, J of Skin, vol. 7, no. 2, p. s164, Mar. 2023, doi: 10.25251/skin.7.supp.164.